Cross Country Healthcare Q3 revenue $636.1M (+70% YoY); guides Q4 revenue $590-600M

CROSS COUNTRY HEALTHCARE INC

2022-Q3 EPS reported $3.97 revenue$2,178,391,000

Revenue $636.1M (+70% YoY, -16% sequential); net income $34.8M ($0.93 diluted EPS).
Adjusted EBITDA $63.8M (10.0% margin), down 24% sequentially from $83.5M.
Repurchased 1M shares for $24.3M at avg $23.97; $87.2M remaining under $100M buyback.
Q4 guidance: Revenue $590-600M (down 6-8% YoY); Adjusted EPS $0.85-$0.95.
Cash from ops $140.6M; closed Mint and Lotus locum tenens acquisitions in October.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CROSS COUNTRY HEALTHCARE INC reported the third quarter ended September 30, 2022 results: revenue $636,098, net income $34,793, EPS $0.93.

Period: the third quarter ended September 30, 2022
Revenue: $636,098
Net income: $34,793
EPS: $0.93
Result: reported results

Exact text from the filing

September 30, 2022. SELECTED FINANCIAL INFORMATION: Variance Variance Q3 2022 vs Q3 2022 vs Dollars are in thousands, except per share amounts Q3 2022 Q3 2021 Q2 2022 Revenue $ 636,098 70 % (16) % Gross profit margin* 22.6 % 20 bps — bps Net income attributable to common stockholders $ 34,793 48 % (34) % Diluted EPS $ 0.93 $ 0.31 $ (0.47) Adjusted EBITDA* $

View on SEC.gov

Browse all earnings releases →

CROSS COUNTRY HEALTHCARE INC filing history →

Source: SEC EDGAR

accession 0001157523-22-001485

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.